Gross Margin
33.57%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 25.14%.Updated Aug 21, 2026Profit Margin
-13.74%vs Specialty Chemicals peers Updated Aug 21, 2026Operating Margin
10.80%vs Specialty Chemicals peers Updated Aug 21, 2026Return on Assets (TTM)
0.17%vs Specialty Chemicals peers Updated Aug 21, 2026Return on Equity (TTM)
-7.22%vs Specialty Chemicals peers Updated Aug 21, 2026Revenue (TTM)
1.07BCNY158.62M · vs all stocks (USD) Updated Aug 21, 2026Revenue per Share (TTM)
3.81CNYUpdated Aug 21, 2026Quarterly Revenue Growth
-10.30%vs Specialty Chemicals peers Updated Aug 21, 2026Gross Profit (TTM)
268.12MCNY39.87M · vs all stocks (USD) Updated Aug 21, 2026EBITDA (TTM)
171.62MCNY25.52M · vs all stocks (USD) Updated Aug 21, 2026Net Income (TTM)
-146.60MCNY-21.80M · vs all stocks (USD) Updated Aug 21, 2026Quarterly Earnings Growth (YoY)
-21.30%vs Specialty Chemicals peers Updated Aug 21, 2026Operating Cash Flow (TTM)
229.09MCNY34.07M · vs all stocks (USD) Updated Aug 21, 2026Levered Free Cash Flow (TTM)
63.62MCNY9.46M · vs all stocks (USD) Updated Aug 21, 20265-Year Average Dividend Yield
0.47%Updated Aug 21, 2026Payout Ratio
0.00%vs Specialty Chemicals peers Updated Aug 21, 2026Revenue
1.09BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
785.27MCNYFY2025 · Dec 31, 2025Gross Profit
308.80MCNYFY2025 · Dec 31, 2025Operating Income
66.14MCNY9.84M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-135.22MCNYFY2025 · Dec 31, 2025Income Tax Expense
8.36MCNYFY2025 · Dec 31, 2025Net Income
-143.58MCNYFY2025 · Dec 31, 2025EBIT
-119.51MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
171.62MCNYFY2025 · Dec 31, 2025Research & Development
55.08MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
89.52MCNYFY2025 · Dec 31, 2025Other Operating Expenses
21.52MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
6.97MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
15.71MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.5100CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.5100CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
281.52MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
281.52MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-143.58MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-96.07MCNYFY2025 · Dec 31, 2025Free Cash Flow
-213.59MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
351.07MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-143.58MCNYFY2025 · Dec 31, 2025Other Non-cash Items
22.70MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
22.28MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
2.52MCNYFY2025 · Dec 31, 2025Capital Expenditures
-117.52MCNYFY2025 · Dec 31, 2025Purchase of Investments
-29.90MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-147.42MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
261.38MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-259.83MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-17.39MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-15.84MCNYFY2025 · Dec 31, 2025